CD8A and neoplasm: It is worth noting that the most resistant tumor is the one with the two mutations and also the one that after 28 days post implantation only induced an increase in the percentage of CD8+ and granzyme+ cells as compared with the RasV12 that induces phenotype changes more consistent with anti-tumor immunity.